Jim Simons Axonics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Axonics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 53,800 shares of AXNX stock, worth $3.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

53,800

Previous 55,600 3.24%

Holding current value

$3.82 Million

Previous $3.74 Million 0.29%

% of portfolio

0.01%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$67.3 - $69.67 $121,140 - $125,406	-1,800 Reduced 3.24%	53,800 $3.75 Million
Q2 2024 Aug 09, 2024	SELL	$66.47 - $69.65 $9.32 Million - $9.76 Million	-140,200 Reduced 71.6%	55,600 $3.74 Million
Q1 2024 May 13, 2024	BUY	$56.67 - $69.36 $6.02 Million - $7.37 Million	106,300 Added 118.77%	195,800 $13.5 Million
Q4 2023 Feb 13, 2024	BUY	$49.38 - $63.75 $1.64 Million - $2.12 Million	33,300 Added 59.25%	89,500 $5.57 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $14.8 Million - $19 Million	-303,800 Reduced 84.39%	56,200 $3.15 Million
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $9.51 Million - $11.9 Million	-198,100 Reduced 35.5%	360,000 $18.2 Million
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $19.9 Million - $25.4 Million	377,900 Added 209.71%	558,100 $30.5 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $10.7 Million - $13.8 Million	180,200 New	180,200 $11.3 Million
Q1 2021 May 13, 2021	SELL	$49.14 - $59.89 $2.05 Million - $2.5 Million	-41,700 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$42.19 - $51.5 $1.76 Million - $2.15 Million	41,700 New	41,700 $2.08 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account